Reinhardt Seifert

Title: Reinhardt Seifert: Innovator in Ion Channel Technology

Introduction

Reinhardt Seifert is a prominent inventor based in Juelich, Germany. He has made significant contributions to the field of ion channel technology, particularly through his innovative work on genetically modified cyclic-nucleotide controlled ion channels. With a total of 2 patents, his research has the potential to advance our understanding of cellular signaling mechanisms.

Latest Patents

Seifert's latest patents include groundbreaking inventions that focus on enhancing the sensitivity and selectivity of ion channels. The first patent, titled "Genetically modified cyclic-nucleotide controlled ion channels," describes a modification of the subunits to achieve higher sensitivity for cAMP in relation to cGMP compared to the wild type according to Seq ID No. 1 and 2. The second patent, "Genetically modified cyclic-nucleotide controlled ion channels and the use thereof," further elaborates on the alterations made to the subunits, emphasizing their increased sensitivity to cAMP and/or selectivity for cAMP over cGMP.

Career Highlights

Reinhardt Seifert is affiliated with Forschungszentrum Jülich GmbH, a leading research center in Germany. His work at this institution has allowed him to explore the intricate dynamics of ion channels and their implications in various biological processes. His research has garnered attention for its innovative approach and potential applications in medical science.

Collaborations

Throughout his career, Seifert has collaborated with esteemed colleagues, including Ulrich B Kaupp and Heinz-Gerd Körschen. These partnerships have enriched his research endeavors and contributed to the advancement of knowledge in the field of ion channels.

Conclusion

Reinhardt Seifert's contributions to the field of ion channel technology through his patents and research at Forschungszentrum Jülich GmbH highlight his role as a key innovator. His work continues to pave the way for future advancements in cellular signaling and therapeutic applications.